Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 861 of 1,261

  1. US 8492347

    Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

    The Regents of the University of California · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  2. US 8491880

    Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates

    Mersana Therapeutics, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  3. US 8491883

    Treatment of amyotrophic lateral sclerosis using umbilical derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  4. US 8491884

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  5. US 8491890

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  6. US 8492340

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  7. US 8491893

    Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications

    Quantum Immunologics, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  8. US 8492338

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  9. US 8492399

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  10. US 8492373

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  11. US 8492378

    GSK-3β inhibitor

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  12. US 8492397

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  13. US 8492403

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  14. US 8492405

    Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  15. US 8492337

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  16. US 8491886

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  17. US 8492430

    Fused cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  18. US 8492488

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  19. US 8492428

    Small-molecule botulinum toxin inhibitors

    The United States of America as represented by the Secretary of the Army · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  20. US 8492454

    Removable color layer for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  21. US 8487107

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  22. US 8487077

    Simplified one-pot synthesis of [18F]SFB for radiolabeling

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  23. US 8487097

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  24. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.